High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population

British Journal of Cancer

Volumn 73, Issue 8, 1996, Pages 896-901

  Hartmann, A ^a   Blaszyk, H ^a   Saitoh, S ^c   Tsushima, K ^c   Tamura, Y ^c   Cunningham, J M ^a   McGovern, R M ^a   Schroeder, J J ^a   Sommer, S S ^b   Kovach, J S ^a,d  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c HIROSAKI UNIVERSITY   (Japan)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Mutagens; Mutation; p53

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER STATISTICS; ETHNIC GROUP; FEMALE; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GERM LINE; HUMAN; HUMAN TISSUE; INCIDENCE; MORTALITY; POPULATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029919079     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.179     Document Type: Article

References (46)

1. ANDERSEN TI, HOLM R AND NESLAND JM. (1993). Prognostic significance of TP53 alterations in breast carcinoma. Br. J. Cancer, 68, 440-448.
2. BLASZYK H, VAUGHN C, HARTMANN A, MCGOVERN RM, SCHROEDER JJ, CUNNINGHAM J, SCHAID D, SOMMER SS AND KOVACH JS. (1994). Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer. Lancet, 343, 1195-1197.
3. BLASZYK H, HARTMANN A, SCHROEDER JJ, MCGOVERN RM, SOMMER SS AND KOVACH JS. (1995). Rapid and efficient screening for p53 gene mutations by dideoxyfingerprinting (ddF). Biotechniques, 18, 256-260.
4. BORING CC, SQUIRES TS AND TONG T. (1993). Cancer statistics, 1993. CA Cancer J. Clin., 43, 7-26.
5. BRASH DE, RUDOLPH JA, SIMON JA, LIN A, MCKENNA GJ, BADEN HP, HALPERIN AJ AND PONTEN J. (1991). A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl Acad. Sci. USA, 88, 10124-10128.
6. BRESSAC B, KEW M, WANDS J AND OZTURK M. (1991). Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature, 350, 429-431.
7. BROOK JD, MCCURRACH ME, HARLEY HG, BUCKLER AJ, CHURCH D, ABURATANI H, HUNTER K, STATON VP, THIRION J, HUDSON T, SOHN R, ZEMELMAN B, DAIVES J, SHELBOURNE P, BUXTON J, JONES C, JUVONEN V, JOHNSON K, HARPER PS, SHAW DJ AND HOUSEMAN DE. (1992). Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell, 68, 799-808.
8. CARON DE FROMENTEL C AND SOUSSI T. (1992). TP53 tumour suppressor gene: A model for investigating human mutagenesis. Genes Chrom. Cancer, 4, 1-15.
9. CHIBA I, TAKAHASHI T, NAU MM, D'AMICO D, CURIEL DT, MITSUDOMI T, BUCHHAGEN DL, CARBONE D, PIANTADOSI S, KOGA H, REISSMAN PT, SLAMON DJ, HOLMES EC AND MINNA JD. (1990). Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 5, 1603-1610.
10. CHUMAKOV PM AND JENKINS JR. (1991). BstNI/NciI polymorphism of the human p53 gene. Nucleic Acids Res., 19(24), 6969.
11. COLEMAN MP, ESTEVE J, DAMIECKI P, ARSLAN A AND RENARD H. (1993). Trends in cancer incidence and mortality, IARC Scientific Publications: Lyon.
12. COLES C, CONDIE A, CHETTY U, STEEL CM, EVANS JH AND PROSSER J. (1992). p53 mutations in breast cancer. Cancer Res., 52, 5291-5298.
13. DE VRIES EMG, RICKE DO, DE VRIES TN, HARTMANN A, BLASZYK H, SOUSSI T, KOVACH JS AND SOMMER SS. (1996). Database of mutations in the p53 and APC tumour suppressor genes. Human Mutation (in press).
14. DUTTON CM, PAYNTON C AND SOMMER SS. (1993). General method for amplifying regions of very high G + C content. Nucleic Acids. Res., 21(12), 2953-2954.
15. HARRIS CC AND HOLLSTEIN M. (1993). Clinical implications of the p53 tumour-suppressor gene. N. Engl. J. Med., 329, 1318-1327.
16. HARTMANN A, ROSANELLI G, BLASZYK H, CUNNINGHAM J, MCGOVERN RM, SCHROEDER JJ, SCHAID D, KOVACH JS AND SOMMER SS. (1995a). Novel pattern of p53 mutation in breast cancers from Austrian women. J. Clin. Invest., 95, 686-689.
17. HARTMANN A, BLASZYK H, MCGOVERN RM, SCHROEDER JJ, CUNNINGHAM J, DE VRIES EMG, KOVACH JS AND SOMMER SS. (1995b). p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers. Oncogene, 10, 681-688.
18. HSU IC, METCALF RA, SUN T, WELSH JA, WANG NJ AND HARRIS CC. (1991). Mutational hotspot in the p53 gene in human hepatocellular carcinoma. Nature, 350, 427-428.
19. JONES MH AND NAKAMURA Y. (1992). Detection of loss of heterozygosity at the human TP53 locus using a dinnucleotide repeat polymorphism. Genes Chrom. Cancer, 5, 89-90.
20. JONES PA, BUCKLEY JD, HENDERSON BE, ROSS PK AND PIKE MC. (1991). From gene to carcinogen: A rapidly evolving field in molecular epidemiology. Cancer Res., 51, 3617-3620.
21. KOVACH JS, MCGOVERN RM, CASSADY JD, SWANSON SK, WOLD LE, VOGELSTEIN B AND SOMMER SS. (1991). Direct sequencing from touch preparations of human carcinomas: Analysis of p53 mutations in breast carcinomas. J. Natl Cancer Inst., 83, 1004-1009.
22. KOVACH JS, HARTMANN A, BLASZYK H, CUNNINGHAM J, SCHAID D AND SOMMER SS. (1996). Detection of p53 gene mutations in breast cancer by highly sensitive methods can provide important prognostic information. Proc. Natl. Acad. Sci. USA, (in press).
23. LA SPADA AR, WILSON EM, LUBAHN DB, HARDING AE AND FISCHBECK KH. (1992). Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature, 352, 77-79.
24. LAZAR V, HAZARD F, BERTIN F, JANIN N, BELLET D AND BRESSAC B. (1993). Simple sequence repeat polymorphism within the p53 gene. Oncogene, 8, 1703-1705.
25. LI SH, MCINNIS MG, MARGOLIS RL, ANTONARAKIS SE AND ROSS CA. (1993). Novel triplet repeat containing genes in human brain: cloning, expression, and length polymorphisms. Genomics, 16, 572-579.
26. MATLASHEWSKI GJ, TUCK S, PIM D, LAMB P, SCHNEIDER J AND CRAWFORD LV. (1987). Primary structure polymorphism at amino acid residue 72 of human p 53. Mol. Cell. Biol., 7, 961-963.
27. MAZARS R, SPINARDI L, BENCHEIKH M, SIMONY-LAFONTAINE J, JEANTEUR P AND THEILLET C. (1992). p53 mutations occur in aggressive breast cancer. Cancer Res., 52, 3918-3923.
28. MOLES JP, MOYRET C, BUILLOT B, JEANTEUR P, GUILHOU JJ, THEILLET C AND BASSET-SEGUIN N. (1993). p53 gene mutations in human epithelial skin cancers. Oncogene, 8, 583-588.
29. MOMAND J, ZAMBETTI GP, OLSON DC, GEORGE D AND LEVINE AJ. (1992). The mdm-2oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245.
30. OLINER JD, PIETENPOL JA, THIAGALINGAM S, GYURIS J, KINZLER KW AND VOGELSTEIN B. (1993). Oncoprotein MDM2 conceals the activation domain of tumour suppressor of p53. Nature, 362, 857-860.
31. PIGNON JM, VINATIER I, FANEN P, JONVEAUX P, TOURNILHAE O, IMBERT M, ROCHANT H AND GOOSENS M. (1994). Exhaustive analysis of the p53 gene coding sequence by dematuring gradient gel electrophoresis: application to the detection of point mutations in acute leukemias. Human Mutation, 3, 126-132.
32. SAITOH S, CUNNINGHAM J, DE VRIES EMG, MCGOVERN RM, SCHROEDER JJ, HARTMANN A, BLASZYK H, WOLD LE, SCHAID D, SOMMER SS AND KOVACH JS. (1994). p53 gene mutations in breast cancers in Midwestern US women: null as well as missense-type mutations are associated with poor prognosis. Oncogene, 9, 2869-2875.
33. SARKAR G, YOON H-S AND SOMMER SS, (1992). Dideoxy fingerprinting (ddF): A rapid and efficient screen for the presence of mutations. Genomics, 13, 441-443.
34. SASA M. KONDO K, KOMAKI K, UYAMA T, MORIMOTO T AND MONDEN Y. (1993). Frequency of spontaneous p53 mutations (CpG site) in breast cancer in Japan. Breast Cancer Res. Treat., 27, 247-252.
35. SHIELDS PG AND HARRIS CC. (1991). Molecular epidemiology and the genetics of environmental cancer. JAMA, 266, 681-687.
36. SIDRANSKY D, VON ESCHENBACH A, TSAI YC, JONES P, SUMMERHAYES I, MARSHALL F, PAUL M, GREEN P, HAMILTON SR, FROST P AND VOGELSTEIN B. (1991). Identification of p53 gene mutations in bladder cancers and urine samples. Science, 252, 706-709.
37. SOMMER SS. (1990). Mutagen test. Nature, 346, 22-23.
38. SOMMER SS AND VIELHABER EL. (1994). Phage promoter-based methods for sequencing and screening for mutations. In The Polymerase Chain Reaction, Ferre F, RA Gibbs (eds). pp.214-220. Birkhauser: Boston.
39. SOMMER SS, CUNNINGHAM J, MCGOVERN RM, SAITOH S, SCHROEDER JJ, WOLD LE AND KOVACH JS. (1992). Pattern of p53 gene mutations in breast cancers of women of the midwestern United States. J. Natl Cancer Inst., 84, 246-252.
40. SOUSSI T, CARON DE FROMENTEL C AND MAY P. (1990). Structural aspects of the p53 protein in relation to gene evolution. Oncogene, 5, 945-952.
41. STATXACT, ver 2.0, 1991. Cytel Software Corporation, Cambridge, MA.
42. STEMMERMANN GN. (1991). The pathology of breast cancer in Japanese women compared to other ethnic groups: a review. Breast Cancer Res. Treat., 18, 67-72.
43. STOFLET ES, KOEBERL DS, SARKAR G AND SOMMER SS. (1988). Genomic amplification with transcript sequencing. Science, 239, 491-494
44. THORLACIUS S, BORRESEN A-L AND EYFJORD JE. (1993). Somatic p53 mutations in human breast carcinomas in an icelandic population: A prognostic factor. Cancer Res., 53, 1637-1641.
45. TSUDA H, IWAYA K, FUKUTOMI T AND HIROHASHI S. (1993). p53 mutations and c-erbB-2 amplificaton in intraductal and invasive breast carcinomas of high histologic grade. Jpn. J. Cancer Res., 84, 394-401.
46. WEISSENBACH J, GYAPAY C, DIB C, VIGNAL A, MORISSETTE J, MILLASSEAU P, VAYSSEIX G AND LATHROP M. (1992). A second generation linkage map of the human gene. Nature, 359, 794-801.